Study of Irinotecan Administered as a Continuous Infusion and Radiation Therapy for Upper Gastrointestinal Cancers
PHASE1CompletedINTERVENTIONAL
Enrollment
22
Participants
Timeline
Start Date
December 31, 2000
Primary Completion Date
October 31, 2007
Study Completion Date
July 31, 2009
Conditions
Pancreatic CancerGastric CancerDuodenum CancerBile Duct Cancer
Interventions
DRUG
irinotecan
PROCEDURE
radiation therapy
Trial Locations (1)
90033
U.S.C./Norris Cancer Center, Los Angeles
All Listed Sponsors
lead
University of Southern California
OTHER
NCT00183846 - Study of Irinotecan Administered as a Continuous Infusion and Radiation Therapy for Upper Gastrointestinal Cancers | Biotech Hunter | Biotech Hunter